{
    "2020-07-31": [
        [
            {
                "time": "2023-10-05",
                "original_text": "AbbVie Earnings Top, Drug Giant Rebounds Bullishly, Flashes Buy Signal",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Drug",
                        "Giant",
                        "Rebounds",
                        "Buy",
                        "Signal"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie's (ABBV) Q2 Earnings and Revenues Beat Estimates",
                "features": {
                    "keywords": [
                        "Q2",
                        "Earnings",
                        "Revenues",
                        "Beat",
                        "Estimates"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Pharma Stock Roundup: Q2 Earnings & J&J and PFE's Coronavirus Updates in Focus",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Roundup",
                        "Q2",
                        "Earnings",
                        "J&J",
                        "PFE",
                        "Coronavirus",
                        "Updates"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "5 Key Things You'll Want to Know About AbbVie's Q2 Update",
                "features": {
                    "keywords": [
                        "Key",
                        "Things",
                        "Q2",
                        "Update"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Let's Not Overlook AbbVie's Q2 Beat",
                "features": {
                    "keywords": [
                        "Not",
                        "Overlook",
                        "Q2",
                        "Beat"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie Beats Earnings Expectations but Stock Falls Anyway",
                "features": {
                    "keywords": [
                        "Beats",
                        "Earnings",
                        "Expectations",
                        "Stock",
                        "Falls"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Earnings & Economic Data Deluge",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Economic",
                        "Data",
                        "Deluge"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "economy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie Shares Climb After Adjusted Profit Beats Analyst Views",
                "features": {
                    "keywords": [
                        "Shares",
                        "Climb",
                        "Adjusted",
                        "Profit",
                        "Beats",
                        "Analyst",
                        "Views"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie (ABBV) Q2 Earnings and Revenues Beat Estimates",
                "features": {
                    "keywords": [
                        "Q2",
                        "Earnings",
                        "Revenues",
                        "Beat",
                        "Estimates"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie shares rises on strong Q2, though cosmetic Botox sales tumbled 43%",
                "features": {
                    "keywords": [
                        "shares",
                        "rises",
                        "strong",
                        "Q2",
                        "cosmetic",
                        "Botox",
                        "sales",
                        "tumbled"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie's Humira powers profit beat as COVID-19 weighs on Botox sales",
                "features": {
                    "keywords": [
                        "Humira",
                        "powers",
                        "profit",
                        "beat",
                        "COVID-19",
                        "weighs",
                        "Botox",
                        "sales"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            }
        ]
    ]
}